Home Newsletters Immune Regulation News The Development of Chiral Nanoparticles to Target NK Cells and CD8+ T...

The Development of Chiral Nanoparticles to Target NK Cells and CD8+ T Cells for Cancer Immunotherapy

By
Justin.choi
-
0
Researchers investigated the immunological effect of chiral nanomaterials as therapeutic and preventive options against tumors.
[Advanced Materials]

Sorry, but the selected Zotpress account can't be found.

Abstract

RELATED ARTICLES

Exit mobile version